Jiuzhou chem is committed to the research & development, production, and sale of active pharmaceutical ingredients (APIs). In addition, the company offers one-stop CDMO services for global pharmaceutical giants in Asia, Europe and North America. Jiuzhou Pharma is the top API manufacturer and supplier of Carbamazepine, Oxcarbazepine, Ketoprofen and Gliclazide worldwide. The company has been honored with a number of industry and government accolades including, “Top 100 in the Chinese Pharmaceutical Industry ”, “China's Leading Exporter of APIs”, “National High-Tech Enterprise”, “National Technology Innovation Demonstration Enterprises”，“Zhejiang ‘Sanming’ Cultivation Pilot Enterprises”，“Zhejiang Innovative Leading Enterprises”, etc.. “Jiuzhou” is widely regarded as the most well-known export brand to come out of Zhejiang.
Jiuzhou’s API is highly competitive internationally. The company has a sterling track record with regulatory authorities including the FDA and EDQM. Jiuzhou has diverse API experience and a robust pipeline which includes central nervous system drugs, non-steroidal drugs, anti-infection drugs, hypoglycemic drugs, tumor treatment drugs, anti-depressant drugs, Parkinson treatment drugs, HCV drugs, diabetes drugs and respiratory anti-infection drugs. The company’s experience across many areas of pharmaceutical manufacturing and history of excellence makes for a bright future.
At Jiuzhou, we are committed to excellence. The manufacturing and research systems and processes we have in place are mature and reflect this commitment. The company has three production sites located in Taizhou, Zhejiang and Yancheng, Jiangsu. Jiuzhou’s R&D division includes innovation platforms like our National Certified Enterprise Technology Center, National Post-Doctoral Scientific Research Workstation, Provincial Academician Expert Workstation and Research Institute of Key Enterprises in Zhejiang. There are R&D centers in Hangzhou, Taizhou and the Unite
China